Skip to main content
. 2016 Mar 9;21(3):329. doi: 10.3390/molecules21030329

Table 4.

Cytotoxic properties of the potent synthesized heterocyclic chalcones on noncancerous LLC-PK1 cells.

Compounds % Cell Viability on Noncancer LLC-PK1 cells
100 μM 50 μM 10 μM
7 94.8 ± 7.6 109.4 ± 10.9 100.2 ± 6.5
8 105.2 ± 5.4 103.2 ± 6.4 97.3 ± 10.2
9 97.1 ± 5.0 98.2 ± 7.3 98.8 ± 10.6
16 104.3 ± 6.5 101.9 ± 12.1 99.1 ± 3.1
Paclitaxel (reference) 20 μM 10 μM 2 μM
75.0 ± 3.6 108.1 ± 8.2 103.4 ± 6.0